Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Wiener Boerse
01/10/2026
|
5-day change | 1st Jan Change | ||
| 57.65 EUR | -3.11% |
|
-3.27% | -8.93% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.94B 3.3B 2.74B 2.5B 4.71B 318B 4.75B 33.16B 12.85B 162B 12.4B 12.14B 521B | P/E 2026 * |
19.4x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 2.93B 3.29B 2.73B 2.49B 4.7B 317B 4.74B 33.06B 12.81B 162B 12.37B 12.1B 520B | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 3.21x |
| Free-Float |
31.63% | Yield 2026 * |
1.7% | Yield 2027 * | 2.02% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
Tradegate
| 41L | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Berne S.E.
| 41L | End-of-day quote | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -3.11% | ||
| 1 week | -3.27% | ||
| Current month | -3.11% | ||
| 1 month | -4.16% | ||
| 3 months | +1.50% | ||
| 6 months | -29.52% | ||
| Current year | -8.93% |
| 1 week | 57.05 |  | 60.5 |
| 1 month | 57.05 | | 60.5 |
| Current year | 53.15 | | 86.6 |
| 1 year | 53.15 | | 86.6 |
| 3 years | 45.82 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 26/07/2007 | |
| Director of Finance/CFO | - | 31/12/2000 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 16/07/2021 | |
| Director/Board Member | - | 26/07/2007 | |
| Director/Board Member | - | 26/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.11% | -3.27% | - | - | 3.3B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -1.00% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 871M 722M 658M 1.24B 83.75B 1.25B 8.74B 3.39B 42.81B 3.27B 3.2B 137B | 892M 1B 833M 759M 1.43B 96.56B 1.45B 10.08B 3.91B 49.36B 3.77B 3.69B 158B |
| Net income | 146M 165M 137M 124M 235M 15.82B 237M 1.65B 640M 8.09B 618M 605M 25.96B | 173M 195M 161M 147M 277M 18.71B 280M 1.95B 757M 9.56B 731M 715M 30.69B |
| Net Debt | -8.5M -9.57M -7.93M -7.23M -13.64M -920M -13.76M -96M -37.2M -470M -35.92M -35.14M -1.51B | -72.51M -81.61M -67.67M -61.68M -116M -7.85B -117M -819M -317M -4.01B -306M -300M -12.87B |
| Date | Price | Change |
|---|---|---|
| 02/10/26 | €57.35 | -0.52% |
| 01/10/26 | €57.65 | -3.11% |
| 30/09/26 | €59.50 | -0.92% |
| 29/09/26 | €60.05 | +0.59% |
| 28/09/26 | €59.70 | +0.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
